40
Views
5
CrossRef citations to date
0
Altmetric
Review

Vesicoureteral reflux – current treatment options

Pages 1959-1966 | Published online: 02 Mar 2005

Bibliography

  • GREENFIELD SP, WAN J: The diagnosis and medical management of primary vesicoureteral reflux. In: Pediatric Urology Gearhart JP, Rink RC, Mouriquand PDE, (Eds). WB Saunders Co., Philadelphia, USA (2001):382–410.
  • GREENFIELD SP: Management of vesicoureteral reflux in children. Current Urology Reports (2001) 2:113–121.
  • •A review of contemporary management of children with VUR.
  • WOODWELL DA: Office visits to urologists: United States 1989–1990. Advance data from vital and health statistics; no. 234. Hyattsville (MD): National Center for Health Statistics. (1993):1–9.
  • GREENFIELD SP, NG M, WAN J: Experience with vesicoureteral reflux in children: clinical characteristics." Um]. (1997) 158:574–577.
  • BAKSHANDEH K, LYNNE C, CARRION H: Vesicoureteral reflux and end stage renal disease. Int. Urol. (1976) 116:557–558.
  • KINCAID-SMITH P, BASTOS MG, BECKER GJ: Reflux nephropathy in the adult. In: Reflux Nephropathy Update. Hodson CJ, Heptinstall RH, Winberg J (Eds), S Karger, Basel, Switzerland (1984):94–101.
  • STILL JL, COTTOM D: Severe hypertension in children. Arch. Dis. Child (1967) 42:34–39.
  • LONDE S: Causes of hypertension in the young. Pediatr. Clin. North Am. (1978) 25:55–65.
  • VALLEE JP, VALLEE MP, GREENFIELD SP: Contemporary incidence of morbidity related to vesicoureteral reflux. Urology (1999) 53:812–815.
  • WARADY BA, HERBERT D,SULLIVAN EK: Annual report of the North American Pediatric Renal TransplantCooperative Study Pediatric Nephrology (1997) 11:49–64.
  • WAN J, GREENFIELD SP, NG M: Sibling reflux: a dual center retrospective study. " Urol. (1996) 156:677–679.
  • ZERIN M, RITCHEY ML,CHANG ACH: Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and renal anomalies. Radiology (1993) 187:157–160.
  • WAN J, GREENFIELD SP, TALLEY M: An analysis of social and economic factors associated with follow up of patients with vesicouretral reflux. " Urol. (1996) 156:668–672.
  • GREENFIELD SP, WAN J: Vesicoureteralreflux: practical aspects of evaluation and management. Pediatr. Nephrol. (1996) 10:789–794.
  • DITCHFIELD MR, DE CAMPO JF, NOLAN TM: Risk factors in the development of early renal cortical defects in children with urinary tract infection. Am.j Roentgenol (1994) 162:1393–1397.
  • WINBERG J: Progressive renal damage from infection with or without reflux (commentary). J. Urol (1992) 148:1733–1734.
  • BIRMINGHAM REFLUX STUDY GROUP: Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Br. Med. J. (1987) 295:237–241.
  • SMELLIE JM, POULTON A, PRESCOD N: Retrospective study of children with renal scarring associated with reflux and urinary tract infection. Br. Med. J. (1994) 308:1193–1196.
  • SHIMADA K, MATSUI T, OGINO T: Renal growth and progression of reflux nephropathy in children with vesicoureteral reflux. J. Urol. (1988) 140:1097–1100.
  • NASSEER SR, STEINHARDT GF: New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation.' Urol. (1997) 158:566–568.
  • COOPER CS, CHUNG BI, KIRSCH AJ: The outcome of stopping prophylactic antibiotics in older children withvesicoureteral reflux. J. Urol (2000) 163:269–273.
  • THOMPSON RH, CHEN JJ, PUGATCH J: Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. I Urol (2001) 166:1465–1469.
  • SILLEN U, BACHELARD M, HERMANSON G: Gross bilateral reflux in infants: gradual decrease of initial detrusor hypercontractility. Urol (1996) 155:668–672.
  • WAN J, KAPLINSKY R, GREENFIELD SP: Toilet habits of children evaluated for urinary tract infection.' Um]. (1995) 154:797–799.
  • KOFF SA: Relationship between dysfunctional voiding and reflux. Urol (1992) 148:1703–1705.
  • SILLEN U: Bladder dysfunction in children with vesicoureteral reflux. Acta. Paediatr. Sapp]. (1999) 431:40–47.
  • SOYGER T, ARIKAN N, YESILLI C: Relationship among pediatric voiding dysfunction and vesicoureteral reflux and renal scars. Urology (1999) 54:905–908.
  • KOFF SA, WAGNER TT, JAYANTHI VR: The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux, and urinary tract infections in children. J. Um]. (1998) 160:1019–1022.
  • WILLEMSEN J, NIJMAN RJM: Vesicoureteral reflux and videourodynamic studies: results of a prospective study. Urology (2000) 55:939–943.
  • CHANDRA M, MADDIX H: Urodynamic dysfunction in infants with vesicoureteral reflux. J. Pediatr. (2000) 136:754–759.
  • SCHOLTMEIJER RJ, NIJMAN RJ: Vesicoureteral reflux and videourodynamic studies: results of a prospective study after three years of follow up. Urology (1994) 43:714–718.
  • MUNDING M, WESSELS H, THORNBERRY B: Use of tolterodine in children with dysfunctional voiding: an initial report. j. Um]. (2001) 165:926–928.
  • GLEASON DM, SUSSET J, WHITE C:Evaluation of a new once daily formulation of oxybutynin for the treatment of urinaryurge incontinence. Urology (1999) 54:420–423.
  • DMOCHOWSKI RR, DAVILA GW, ZINNER NR: Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. Urol. (2002) 168: 580–586.
  • PARK JM, RETIK AB: Surgery for vesicoureteral reflux. In: Pediatric Urology Gearhart JP, Rink RC, Moutiquand PDE, (Eds), WB Saunders Co., Philadelphia, USA (2001):421–429.
  • ELDER J: Guidelines for consideration for surgical repair of vesicoureteral reflux. Carr: Opin. Urol. (2000) 10:579–585.
  • LAKSHMANAN Y, FUNG LCT: Laparoscopic extravesicular ureteral reimplantation for vesicoureteral reflux: recent technical advances. J. Endourol (2000) 14: 589–594.
  • OKAMURA K, KATO N, TSUJI, Y: A comparative study of endoscopic trigonoplasty for vesicoureteral reflux in children and in adults. Int. Urol. (1999) 6:562–566.
  • STENBERG A, HENSLE TW, LACKGREN G: Vesicoureteral reflux: a new treatment algorithm. Curr. Urol. Rep. (2002) 3:107–114.
  • •An excellent overview of the rationale of the use of cystoscopic bulking agents.
  • O'DONNELL B, PURI P: Treatment of vesicoureteral reflux by endoscopic injection of Teflon. Br. Med. J. (1984) 289:7–9.
  • CHERTIN B, COLHOUN E, MURGESH V: Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. Urol (2002) 167:1443–1446.
  • PURI P: Endoscopic correction of vesicoureteral reflux. Can: Opin. Urol. (2000) 10:593–597.
  • HUGHES PD: Ureteric reflux in adults and children treated exclusively by endoscopic Teflon injection: a 10-year experience. Aust. N41. Slug. (1999) 69:856–859.
  • STEYAERT H, SATTONET C, BLOCH C:Migration of PTFE paste particles to the kidney after treatment for vesico-ureteric reflux. BIU Int (2000) 85:168–169.
  • KERSHEN RT, ATALA A: New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol. Clin. N Amer. (1999) 26:81–94.
  • •A thorough discussion of new advances in cystoscopic treatment of VUR.
  • DE GRAZIA E, CIMADOR M: Long termfollow-up results of vesico-ureteral reflux treated with subureteral collagen injection (SCIN). Min. Pediatr. (2003) 52:7–14.
  • INOUE K, NAKAMOTO T, USUI A: Endoscopic subureteral gluteraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults. I Urol. (2000) 164:336–339.
  • HAFERKAMP A, CONTRACTOR H, MOHRING K: Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up. Urology (2000) 55:759–763.
  • HAFERKAMP A, MOHRING K, STAEHLER G: Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. Urol (2000) 163:274–277.
  • HAFERKAMP A, MOHRING K, STAEHLER G: Pitfalls of repeat subureteral bovine collagen injections for endoscopic treatment of vesicouretertal reflux. J. Urol. (2000) 163:1919–1921.
  • TSUBOI N, HORIUC HI K, OSAWA S: Endoscopic treatment of vesicoureteral reflux in children with gluteraldehyde cross-linked bovine dermal collagen. J. Nippon Med. Sch. (2000) 67:9–12.
  • CAPOZZA N, PATRICOLO M, LAIS A: Endoscopic treatment of vesico-ureteric reflux: twelve years' experience. Urol. Int. 67:228–231.
  • PALMA PC, RICCETTO CL,HERRMANN V: Repeated lipoinjections for stress urinary incontinence. J. Endourol (1997) 11:67.
  • KERSHEN RT, FEFER SD, ATALA A: Tissue-engineered therapies for the treatment of urinary incontinence and vesicoureteral reflux. World j Urol. (2000) 18:51–55.
  • DIAMOND DA, CALDAMONE AA: Endoscopic treatment of vesicoureteric reflux in children using autologous chondrocyte: preliminary results. J. Urol. (1999) 162:1185–1188.
  • MCHEIKJN, BACQUEY C, VERGNES P: Phagocytic reaction in contact with macroplastic: application in pediatric surgery. Ped. Surg. (2000) 35:1474–1477.
  • OSWALD J, RICCABONA M, LUSUARDI L: Prospective comparisonand 1-year follow-up of a single endoscopic subureteral polymethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology (2002) 60:894–898.
  • GIACOMELLO L, CAMOGLIO ES, CECCHETO M: Endoscopic treatment of vesico-ureteral reflux and urinary incontinence. Ped. Med. Chir (2002) 24:134–136.
  • CAPOZZA N, CAIONE P:Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a comparison with antibiotic prophylaxis. Peds. (2002) 140:230–234.
  • STENBERG AM, LACKGREN G: A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short term clinical results. J. Urol. (1995) 154:800–803.
  • STENBERG A, LARSSON E, LACKGREN G: Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. Urol. (2003) 169:1109–1113.
  • LACKGREN G, WAHLIN N, STENBERG A: Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr. Stoll (1999) 431:62–71.
  • LACKGREN G, WAHLIN N, SKOLDENBERG E: Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J. Urol (2001) 166:1887–1892.
  • KIRSCH AJ, PEREZ-BRAYFIELD MR, SCHERZ HC: Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospital of Atlanta experience. J. Urol. (2003) 170:211–215.
  • ELDER J, PETERS CA ARANT BS: Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. Urol. (1997) 157:1846–1851.
  • •A summary of the American Urologic Association guidelines panel report.
  • MATHEWS R, NASLUND M, DOCIMO S: Cost analysis of the treatment of vesicoureteral reflux: a computer model. Urol. (2000) 163:561–566.
  • KOBELT G, CANNING DA,HENSLE TW: The cost effectiveness of endoscopic injection ofdextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J. Urol. (2003) 169:1480–1485.
  • POLITANO V: Vesicoureteral reflux. In: Urologic Surgery Glenn JF (Ed.). Harper & Row, New York, USA (1975):272–293.
  • WALKER RD: Vesicoureteral reflux In: Adult and Pediatric Urology (Vol 2). Gillenwater JW, Grayhack JT, Howards SS (Eds), Year Book Medical Publishers, Chicago, USA (1987):1676–1708.Affiliation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.